Web1 de out. de 2024 · The overall survival rates at 1 month, 1 year, and 5 years were 89%, 82% and 79%, respectively. On multivariate analysis, only number of red blood cell … WebLong-term survival benefit from treatment at a specialty center after cardiac arrest Long-term survival benefit from treatment at a specialty center after cardiac arrest …
Frontiers Long-term survival benefits of intrathecal autologous …
Web26 de abr. de 2024 · Nivolumab continues to demonstrate a substantial survival benefit over docetaxel at 5 years in advanced non-small cell lung cancer (NSCLC) patients who progressed on platinum-based therapies, according to a pooled analysis of two phase 3 trials published in the Journal of Clinical Oncology.. Across the two studies – CheckMate … Web23 de nov. de 2024 · Previous analyses demonstrating the survival benefit of eculizumab in patients with PNH leveraged historical data and were limited by small patient numbers … allstate pto
Long-term survival with first-line nivolumab plus ipilimumab in ...
Web1 de fev. de 2016 · The use of prolonged maintenance immunosuppressive therapy after kidney transplantation has improved the short-term outcomes, 1 but the effect on long … Web9 de set. de 2024 · Two studies report long-term survival benefits with olaparib in ovarian cancer 9 Sept 2024 ESMO Congress 2024 The PARP inhibitor shows durable clinical … Web1 de fev. de 2015 · Kim and Braunwald (28) suggested that late myocardial reperfusion confers several benefits, including recovered left ventricular function and improved survival resulting from myocardial salvage, which has given rise to what has been called the “open-artery hypothesis.” allstate pto policy